Literature DB >> 33341941

Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.

Camille Lenoir1,2, Youssef Daali1,2, Victoria Rollason1, François Curtin1, Yvonne Gloor1, Marija Bosilkovska1, Bernhard Walder3, Cem Gabay4, Michael John Nissen4, Jules Alexandre Desmeules1,2, Didier Hannouche5, Caroline Flora Samer1.   

Abstract

Cytochromes P450 (CYP) are subject to important interindividual variability in their activity due to genetic and environmental factors and some diseases. Limited human data support the idea that inflammation downregulates CYP activities. Our study aimed to evaluate the impact of orthopedic surgery (acute inflammation model) on the activity of six human CYP. This prospective observational study was conducted in 30 patients who underwent elective hip surgery at the Geneva University Hospitals in Switzerland. The Geneva phenotyping cocktail containing caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan, and midazolam as probe drugs respectively assessing CYP1A2, 2B6, 2C9, 2C19, 2D6, and 3A activities was administered orally before surgery, day 1 (D1) and 3 (D3) postsurgery and at discharge. Capillary blood samples were collected 2 hours after cocktail intake to assess metabolic ratios (MRs). Serum inflammatory markers (CRP, IL-6, IL-1β, TNF-α, and IFN-γ) were also measured in blood. CYP1A2 MRs decreased by 53% (P < 0.0001) between baseline and the nadir at D1. CYP2C19 and CYP3A activities (MRs) decreased by 57% (P = 0.0002) and 61% (P < 0.0001), respectively, with the nadir at D3. CYP2B6 and CYP2C9 MRs increased by 120% (P < 0.0001) and 79% (P = 0.018), respectively, and peaked at D1. Surgery did not have a significant impact on CYP2D6 MR. Hip surgery was a good acute inflammation model as CRP, IL-6, and TNF-α peak levels were reached between D1 and day 2 (D2). Acute inflammation modulated CYP activity in an isoform-specific manner, with different magnitudes and kinetics. Acute inflammation may thus have a clinically relevant impact on the pharmacokinetics of these CYP substrates.
© 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Year:  2021        PMID: 33341941     DOI: 10.1002/cpt.2146

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Pharmacogenetic Gene-Drug Associations in Pediatric Burn and Surgery Patients.

Authors:  Kristin N Grimsrud; Ryan R Davis; Clifford G Tepper; Tina L Palmieri
Journal:  J Burn Care Res       Date:  2022-09-01       Impact factor: 1.819

2.  Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients.

Authors:  Felix Stader; Manuel Battegay; Parham Sendi; Catia Marzolini
Journal:  Clin Pharmacol Ther       Date:  2021-09-22       Impact factor: 6.903

Review 3.  Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies.

Authors:  Milo Gatti; Fabrizio De Ponti; Federico Pea
Journal:  CNS Drugs       Date:  2021-04-18       Impact factor: 5.749

4.  Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.

Authors:  Camille Lenoir; Amine Niederer; Victoria Rollason; Jules Alexandre Desmeules; Youssef Daali; Caroline Flora Samer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-11-17

5.  Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.

Authors:  Camille Lenoir; Frédérique Rodieux; Jules A Desmeules; Victoria Rollason; Caroline F Samer
Journal:  Clin Pharmacokinet       Date:  2021-08-31       Impact factor: 6.447

6.  Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities.

Authors:  Brahim Achour; Pauline Gosselin; Amin Rostami-Hodjegan; Jean-Luc Reny; Jean Terrier; Yvonne Gloor; Zubida M Al-Majdoub; Thomas M Polasek; Youssef Daali
Journal:  Clin Pharmacol Ther       Date:  2022-03-28       Impact factor: 6.903

Review 7.  Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19.

Authors:  Azam Hosseinzadeh; Abolfazl Bagherifard; Fereshteh Koosha; Shiva Amiri; Arman Karimi-Behnagh; Russel J Reiter; Saeed Mehrzadi
Journal:  Life Sci       Date:  2022-08-06       Impact factor: 6.780

Review 8.  The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug-Disease Interaction Under Different Clinical Conditions.

Authors:  Milo Gatti; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2022-09-05       Impact factor: 5.577

Review 9.  A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling.

Authors:  Laura M de Jong; Sylvia D Klomp; Nicoline Treijtel; Robert Rissmann; Jesse J Swen; Martijn L Manson
Journal:  Br J Clin Pharmacol       Date:  2022-06-16       Impact factor: 3.716

10.  Response to "CYP450 3A4/5 Containment During SARS-CoV-2 Infection".

Authors:  Edouard Charles Le Carpentier; Emmanuel Canet; Damien Masson; Ronan Bellouard; Matthieu Grégoire
Journal:  Clin Pharmacol Ther       Date:  2022-09-05       Impact factor: 6.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.